Computational chemistry applications

Computational chemistry applications

An in-depth exploration of computational chemistry applications to solve real-life biological science, materials, and engineering problems.

Computational chemistry allows researchers to explore a large, diverse range of chemical space since it is much easier to draw a molecule on the computer than to synthesize, purify, and characterize a molecule in a lab.

When deployed appropriately, computational chemistry applications can effectively bring molecules to life on the computer by accurately simulating and predicting relevant properties. For instance, the binding affinity of a small-molecule ligand to a protein target can be calculated with a similar accuracy to that of wet lab assays.

Within computational chemistry, physics-based methods grounded in first-principles can enable prediction accuracy matching experimental accuracy and are broadly applicable, but they tend to be more computationally expensive than other methods. Alternatively, machine learning (ML) methods, which develop a model by training on a data set, are also being deployed for molecular design. These ML approaches can generate results much faster but are most effective when exploring chemical space that is related to the data set the machine learning model is built upon, thus limiting their domain of applicability.

Combining physics-based and ML approaches incorporates the strengths of both to speed up scientific advances in molecular design. For example, integrating active learning into physics-based molecular docking allows one to assess very large chemical libraries in an efficient manner while still retaining the high level of performance. With active learning incorporated in docking algorithms, roughly 30,000 compounds can be tested in one second as compared to typical non-ML methods that run at roughly 1 compound per 30 seconds–this represents a 104 times speed up.

Putting Computational Chemistry to Work

Many industries are using computational chemistry methods and molecular modeling to drive innovations in pharmaceutical drugs, packaging materials, batteries, and more. Some applications for computational chemistry include:

  • Drug design
  • Medicinal chemistry design
  • Chemoinformatics
  • Consumer packaged goods
  • Protein/antibody engineering
  • Enzyme design
  • Organic electronics
  • Pharmaceutical formulations
  • Catalysis design
  • Polymer design
  • Surface chemistry
  • Energy capture and storage
  • Lead optimization
  • Drug target validation
  • Semiconductors
  • Peptide design
  • Metals, alloys, and ceramics design

Benefits of Using Computational Chemistry

Computational chemistry aims to simulate and predict molecular structures and properties using different kinds of calculations based on quantum and classical physics. Advances in machine learning are also making computational chemistry more effective by increasing the speed at which calculations can be done.

Computational chemistry methods reduce the time, money, and reagent resources spent on synthesis, assays, and other experimental work. Machine learning applications can further enhance computational chemistry by increasing the speed of complex calculations, sometimes by several orders of magnitude. By carefully integrating machine learning with physics-based algorithms, digital chemical design can easily outpace wet lab design. This time savings directly translates into cost savings. Additionally, these methods allow for a broader expanse of chemical space to be explored, which can result in a greater likelihood of finding unexpected, novel molecules. In the fast-paced world of molecular design, where first-to-patent can mean the difference between success and the loss of a research program, the increase in the speed and breadth afforded by digital chemistry increases the chances of owning intellectual property.

Real-World Computational Chemistry Applications

Computational Chemistry Accelerates Drug Design

When used in drug discovery programs, computational tools allow the exploration of the chemical space with times and costs that cannot be achieved with wet-lab experiments.

For example, recent acceleration of the lead optimization process was made by using a broad search algorithm and cloud computing to explore a huge chemical space–more than 1 billion molecules computationally characterized–towards the goal of designing new inhibitors of d-amino acid oxidase (DAO). DAO is a target for the treatment of schizophrenia. This work shows the application of chemical enumeration, property filtering, machine learning and rigorous free energy perturbation calculations to design new small-molecule drugs and tackle the multiparameter optimization problem.

R&D for Product Development in Consumer Packaged Goods

In the consumer packaged goods (CPG) industry, manufacturers need to consider cost, performance and sustainability when developing new products.

Computational chemistry models and simulations decrease the development timeline and costs by allowing for fast screening, design and testing of new materials. Reckitt, which produces health, hygiene and nutrition consumer products, uses quantum mechanics and molecular dynamics computational tools in their R&D process to speed innovation. They have described how they used digital chemistry in their efforts to design more sustainable materials and how this approach has sped up timelines by 10x on average compared to a solely experimental approach.

Physics-Based Simulations to Develop New Energy Solutions

Another exciting application of computational chemistry approaches is the use of atomic-scale materials modeling in the design of new battery and energy storage solutions.

Some behaviors of materials that have been studied include ion diffusion, electrochemical response in electrodes and electrolytes, dielectric properties, mechanical response, and more. This computational approach has been used to screen for Li-ion battery additives that form a stable solid electrolyte interphase.

Driving R&D with Schrödinger’s Pioneering Computational Platform

At Schrödinger, our physics-based computational platform allows companies worldwide to harness the capabilities of computational chemistry methods and apply these to their R&D programs quickly and with ease. Over the last 30 years, Schrödinger’s modeling software and services have enabled the discovery of high-quality, novel molecules and materials across industries–as illustrated by some of the examples described above.

Molecules come to life in Maestro, the streamlined portal for structural visualization and access to cutting-edge predictive computational modeling and machine learning workflows. And researchers can bring their digital and experimental data side-by-side within LiveDesign, Schrödinger’s enterprise informatics platform for collaborative analysis, molecular design, and program management.

As the predictive and analytical capabilities of physics-based modeling continue to advance and are enhanced by the addition of new ML models, the myriad applications that are impacted by computational chemistry will continue to grow.

References

  1. Advancing Drug Discovery through Enhanced Free Energy Calculations

    2017. Abel R, Wang R, Harder ED, Berne BJ, and Friesner RA. Accounts of Chemical Research. 50(7):1625-1632. DOI: 10.1021/acs.accounts.7b00083

  2. Docking and scoring in virtual screening for drug discovery: methods and applications

    2004. Kitchen D, Decornez H, Furr J, et al. Nature Review Drug Discovery. 3:935–949. DOI: 10.1038/nrd1549

  3. Efficient Exploration of Chemical Space with Docking and Deep Learning

    2021. Yang Y, Yao K, Repasky MP, Leswing K, Abel R, Shoichet BK, and Jerome SV. Journal of Chemical Theory and Computation I. 17(11): 7106-7119. DOI: 10.1021/acs.jctc.1c00810

Chinese: 2022薛定谔秋季中文生命科学网络讲座 | 薛定谔计算模拟技术助力新型 D-氨基酸氧化酶抑制剂的发现

NOV 10, 2022

2022薛定谔秋季中文生命科学网络讲座 | 薛定谔计算模拟技术助力新型 D-氨基酸氧化酶抑制剂的发现

Speaker

Dr. Zhe Nie
Executive Director

Abstract

D-Serine是N-甲基d-天冬氨酸 (NMDA) 受体的共激动剂,而NMDA受体是一种关键的兴奋性神经递质受体。在大脑中,D-Serine由丝氨酸消旋酶从其L-异构体合成,并由 D-氨基酸氧化酶 (DAO, DAAO) 代谢,其中DAO是一种催化D-氨基酸(包括D-Serine)氧化降解的黄素酶, 其产物是相应的α-酮酸。许多研究已经证实了低D-Serine浓度和/或DAO高度表达以及增强酶活性与NMDA功能障碍和精神分裂症之间的关联。至此,许多公司开始探索使用DAO抑制剂治疗精神分裂症和其他适应症的可能性。我们的研究项目基于薛定谔计算建模平台的支持,以开发具有best-in-class性质的新型 DAO 抑制剂。这项研究使用hDAO FEP+模型前瞻性地预测了化合物对hDAO的抑制效力,并通过我们的AutoDesigner算法对人工设计和计算机列举的设计构思进行排序。最后,我们发现了一类具有理想药代动力学和脑渗透特性的新型DAO抑制剂。在体内小鼠 PK/PD 模型中,工具化合物37证明了通过抑制DAO功能对血浆和大脑中D-Serine浓度的调节。持续的SAR工作使DAO在生化和细胞实验中体现的效力得到了显著提高。在项目过程中,我们的建模技术不仅提高了药物化学研发的效率,还有助于识别未曾探索过的子口袋,进一步开发 SAR。

D-Serine is a co-agonist of the N-methyl D-aspartate (NMDA) receptor, a key excitatory neurotransmitter receptor. In the brain, D-Serine is synthesized from its L-isomer by serine racemase and is metabolized by the D-amino acid oxidase (DAO, DAAO), a flavoenzyme that catalyzes the oxidative degradation of D-amino acids including D-serine to the corresponding α-keto acids. Many studies have linked decreased D-serine concentration and/or increased DAO expression and enzyme activity to NMDA dysfunction and schizophrenia. Thus, many companies have explored the possibility of employing DAO inhibitors for the treatment of schizophrenia and other indications. Powered by the Schrödinger computational modeling platform, we initiated a research program to identify novel DAO inhibitors with best-in-class properties. The program execution leveraged an hDAO FEP+ model to prospectively predict compound hDAO inhibitory potency and prioritize design ideas from both human design and computer enumeration by our AutoDesigner algorithm. A novel class of DAO inhibitors with desirable pharmacokinetic and brain penetration properties were discovered from this effort. In an in vivo mouse PK/PD model, tool compound 37 demonstrated modulation of D-serine concentrations in the plasma and brain through inhibition of DAO function. Continued SAR work has led to significant potency improvement in both DAO biochemical and cell assays. Our modeling technology on this program has not only enhanced the efficiency of medicinal chemistry execution, it has also helped to identify a previously unexplored subpocket for further SAR development.

Chinese: 2022薛定谔秋季中文生命科学网络讲座 | AutoDesigner,一种通过快速探索大型化学空间来优化先导化合物的从头设计算法

OCT 27, 2022

2022薛定谔秋季中文生命科学网络讲座 | AutoDesigner,一种通过快速探索大型化学空间来优化先导化合物的从头设计算法

Speaker

Dr. Jianxin Duan
Fellow

Abstract

药物发现中先导优化阶段通常涉及数百至数千个化合物的设计、合成和检测。设计阶段通常利用传统的药物化学方法,同时如果有合适的结构信息,也应用基于结构的药物设计(SBDD)方法。这种方式的两个主要局限性是:(1)难以快速设计出符合多个项目标准的有效分子,或解决多参数优化(MPO)问题;(2)与巨大的化学空间相比,探索的分子数量相对较少。为了解决这些限制,我们开发了AutoDesigner,一种从头设计的算法。AutoDesigner采用了云原生多阶段搜索算法,进行连续的化学空间探索和过滤。在符合项目标准范围内,比如理化性质和活性,我们可以探索和优化百万或几十亿的虚拟化合物。这算法值需要单个有活性数据和假想结合模式的小分子,非常适合早期数据贫乏的SBDD项目。

The lead optimization stage of a drug discovery program generally involves the design, synthesis, and assaying of hundreds to thousands of compounds. The design phase is usually carried out via traditional medicinal chemistry approaches and/or structure-based drug design (SBDD) when suitable structural information is available. Two of the major limitations of this approach are (1) difficulty in rapidly designing potent molecules that adhere to myriad project criteria, or the multiparameter optimization (MPO) problem, and (2) the relatively small number of molecules explored compared to the vast size of chemical space. To address these limitations we have developed AutoDesigner, a de novo design algorithm. AutoDesigner employs a cloud-native, multistage search algorithm to carry out successive rounds of chemical space exploration and filtering. Millions to billions of virtual molecules are explored and optimized while adhering to a customizable set of project criteria such as physicochemical properties and potency. Additionally, the algorithm only requires a single ligand with measurable affinity and a putative binding model as a starting point, making it amenable to the early stages of an SBDD project where limited data are available.

Accelerating Antibody Drug Discovery Through Computational Modeling

OCT 20, 2022

Accelerating Antibody Drug Discovery Through Computational Modeling

Speaker

Eliud Oloo
Senior Principal Scientist

Abstract

The large size and complexity of biologic molecules creates unique sets of safety, efficacy, and developability hurdles that have to be overcome in order to bring biotherapeutics to market. This webinar will provide an overview of computational modeling strategies for antibody design. The presentation will describe how calculated properties derived from physics-based 3D structural analyses and simulation are applied to not only predict binding affinity but also identify and mitigate potential liabilities in the development of antibody-based biotherapeutics. Such computational modeling efforts can contribute to significant reductions in project costs and timelines by directing experimental focus toward the most promising candidates.

Chinese: 应用薛定谔计算平台加速SGR-1505,治疗复发或难治性B细胞淋巴瘤的MALT1异生抑制剂

OCT 13, 2022

应用薛定谔计算平台加速SGR-1505,治疗复发或难治性B细胞淋巴瘤的MALT1异生抑制剂

Speaker

Zhe Nie
Executive Director

Abstract

MALT1(粘膜相关淋巴组织淋巴瘤易位蛋白 1)是 NF-κB 信号通路的关键介质,一部分 B 细胞淋巴瘤的主要驱动因素。它通过与 CARMA1 和 BCL10 形成复合物来介导抗原受体诱导的淋巴细胞活化。 MALT1 被认为是几种亚型非霍奇金 B 细胞淋巴瘤和慢性淋巴细胞白血病 (CLL) 的潜在治疗靶点。应用以 FEP+ 为核心的基于物理的建模技​​术与 机器学习驱动的AutoDesigner 化合物枚举流程等工具相组合的薛定谔计算平台,我们的团队探索了数十亿个设计,在 10 个月“设计、合成、测试”优化周期的迭代中仅合成了先导系列中的 78 个化合物,最终选择 SGR-1505 作为开发候选。 SGR-1505 是一种强效口服变构 MALT1 抑制剂。在多种体内 B 细胞淋巴瘤异种移植模型中,它单独或与 BTK 抑制剂联合使用都显示出强大的抗肿瘤活性。 SGR-1505在复发或难治性 B 细胞淋巴瘤患者中的 1 期临床研究将于今年晚些时候启动。